Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis
Keyword(s):
2016 ◽
Vol 45
(3)
◽
pp. 468-475
◽
Keyword(s):
2013 ◽
Vol 208
(6)
◽
pp. 1000-1007
◽
Keyword(s):
2018 ◽
Vol 120
(5)
◽
pp. 8154-8159
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 4
(3)
◽
pp. 191-196
◽
Keyword(s):
2015 ◽
Vol 51
(4)
◽
pp. 390-403
◽
Keyword(s):